Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

NCT00807248 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

490

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Escitalopram placebo
DRUG: Gaboxadol placebo
DRUG: Escitalopram 20 mg
DRUG: Gaboxadol 5 mg
DRUG: Gaboxadol 10 mg

Sponsor

H. Lundbeck A/S